Mapfre, S.A. MAP.MC
Composite 59/100; the shares have moved about 17% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 43/100 — a slight mark against it.
Income ranks 83/100 — a strong point in its favour. Momentum ranks 74/100 — a moderate point in its favour. Valuation ranks 73/100 — a moderate point in its favour.
Quality ranks 43/100 — a slight mark against it. Balance-sheet strength ranks 45/100 — a slight mark against it.
What the company does Mapfre, S.A. is a diversified insurance group offering life, health, property-casualty, savings, retirement, and reinsurance products across Spain and internationally. It serves corporations, SMEs, professionals, and individuals through direct and digital channels.
Key financials ROE 17.4%, ROA 3.7%, net margin 3.8%, revenue growth 15.1%, EPS growth 4.9%. Debt/equity 0.29, current ratio 35.97, dividend yield 2.5%, payout 46.4%. Forward P/E 8.88, PEG 0.33, P/B 1.33.
Stock health Sideravia scores: Quality 34.2 (weak), Growth 54.5, Strength 36.7, Valuation 72.8, Momentum 68.2, Income 75.6. 12-month momentum +30.88%, RSI 50.00, 52-week range down 5.33%.
Price vs fair value The stock trades at a DISCOUNT of 69.30% to our fair-value estimate of 7.40 and at a PREMIUM of 4.23% to the 12-month target of 4.18. - Insurtech stake in Tuio signals strategic pivot (Life Insurance International 2026-07-31) - “47-year-old insurance stock shocks market with jaw-dropping move” (TheStreet 2026-07-27) - Valuation percentile 72.8/100 flags attractive pricing (analyst data) - Dividend yield 2.5% supports income appeal (company data)
Looking forward Forward P/E compression to 8.88 and PEG of 0.33 suggest earnings recovery is priced in. Execution on the Tuio stake and margin improvement will be key catalysts to close the valuation gap.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.